Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 5011 AL 5025

Erucic acid, a nutritional PPARδ-ligand may influence Huntington's disease pathogenesis

Altinoz MA, Ozpinar A, Ozpinar A, Hacker E.

Metab Brain Dis. 2020 Jan;35(1):1-9. doi: 10.1007/s11011-019-00500-6. Epub 2019 Oct 17.

Exercise, diet and stress as modulators of gut microbiota: Implications for neurodegenerative diseases

Gubert C, Kong G, Renoir T, Hannan AJ.

Neurobiol Dis. 2020 Feb;134:104621. doi: 10.1016/j.nbd.2019.104621. Epub 2019 Oct 16.

Neurological disorders and mitochondria

Cabral-Costa JV, Kowaltowski AJ.

Mol Aspects Med. 2020 Feb;71:100826. doi: 10.1016/j.mam.2019.10.003. Epub 2019 Oct 17.

Voluntary and involuntary movements: A proposal from a clinician

Ugawa Y.

Neurosci Res. 2020 Jul;156:80-87. doi: 10.1016/j.neures.2019.10.001. Epub 2019 Oct 18.

Selective Autophagy Receptors in Neuronal Health and Disease

Conway O, Akpinar HA, Rogov VV, Kirkin V.

J Mol Biol. 2020 Apr 3;432(8):2483-2509. doi: 10.1016/j.jmb.2019.10.013. Epub 2019 Oct 22.

Multidisciplinary rehabilitation reduces hypothalamic grey matter volume loss in individuals with preclinical Huntington's disease: A nine-month pilot study

Bartlett DM, Dominguez D JF, Lazar AS, Kordsachia CC, Rankin TJ, Lo J, Govus AD, Power BD, Lampit A, Eastwood PR, Ziman MR, Cruickshank TM.

J Neurol Sci. 2020 Jan 15;408:116522. doi: 10.1016/j.jns.2019.116522. Epub 2019 Oct 13.

Optimizing intracellular antibodies (intrabodies/nanobodies) to treat neurodegenerative disorders

Messer A, Butler DC.

Neurobiol Dis. 2020 Feb;134:104619. doi: 10.1016/j.nbd.2019.104619. Epub 2019 Oct 25.

Chorea-like symptoms and high blood concentration of ceftriaxone in a patient undergoing hemodialysis: A case report

Yokoyama Y, Hosokawa N, Kudo T, Goda H, Ito K, Suzuki M, Funakoshi R.

J Infect Chemother. 2020 Mar;26(3):285-288. doi: 10.1016/j.jiac.2019.10.005. Epub 2019 Oct 31.

ATTEC: a potential new approach to target proteinopathies

Li Z, Zhu C, Ding Y, Fei Y, Lu B.

Autophagy. 2020 Jan;16(1):185-187. doi: 10.1080/15548627.2019.1688556. Epub 2019 Nov 7.

Does kynurenic acid act on nicotinic receptors? An assessment of the evidence

Stone TW.

J Neurochem. 2020 Mar;152(6):627-649. doi: 10.1111/jnc.14907. Epub 2019 Nov 24.

Deterioration of neuroregenerative plasticity in association with testicular atrophy and dysregulation of the hypothalamic-pituitary-gonadal (HPG) axis in Huntington's disease: A putative role of the huntingtin gene in steroidogenesis

Selvaraj K, Manickam N, Kumaran E, Thangadurai K, Elumalai G, Sekar A, Radhakrishnan RK, Kandasamy M.

J Steroid Biochem Mol Biol. 2020 Mar;197:105526. doi: 10.1016/j.jsbmb.2019.105526. Epub 2019 Nov 9.

Melatonin: A review of its potential functions and effects on neurological diseases

Gunata M, Parlakpinar H, Acet HA.

Rev Neurol (Paris). 2020 Mar;176(3):148-165. doi: 10.1016/j.neurol.2019.07.025. Epub 2019 Nov 11.

Chorea-acanthocytosis associated with two novel heterozygous mutations in the VPS13A gene

Verkkoniemi-Ahola A, Kuuluvainen L, Kivirikko S, Myllykangas L, Pöyhönen M.

J Neurol Sci. 2020 Jan 15;408:116555. doi: 10.1016/j.jns.2019.116555. Epub 2019 Oct 31.

Specific cognitive theory of mind and behavioral dysfunctions in early manifest Huntington disease: a case report

Caillaud M, Laisney M, Bejanin A, Scherer-Gagou C, Bonneau D, Duclos H, Eustache F, Verny C, Desgranges B, Allain P.

Neurocase. 2020 Feb;26(1):36-41. doi: 10.1080/13554794.2019.1696837. Epub 2019 Nov 26.

The globus pallidus as a target for neuropeptides and endocannabinoids participating in central activities

Chen XY, Xue Y, Chen H, Chen L.

Peptides. 2020 Feb;124:170210. doi: 10.1016/j.peptides.2019.170210. Epub 2019 Nov 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias